Scar Management Market Size is valued at USD 1.02 Bn in 2022 and is predicted to reach USD 1.64 Bn by the year 2031 at a 5.61% CAGR during the forecast period for 2023-2031.
The scars management market is natural and inevitable, in which fibrous tissue replaces normal tissue. Collagen is initially generated randomly, forming fibrous clumps, and then remodels along lines of strain. There is a potential for adhesions to start in the neighbouring tissues as this natural process unfolds. As the global surgical procedure volume, scar management awareness, innovative treatment choices, consumer disposable income, and the elderly population all rise, the global scar treatment market is predicted to expand rapidly throughout the projected period. Scars are a common consequence of injury or surgery and can have psychological as well as physiological effects on patients.
The advent of laser therapy has brought about significant technological advancements in the scar treatment sector. The rising rate of traffic collisions is also a major element driving the expansion of this industry.
However, the scar management market is expected to expand, although it may face challenges from elements like the high price of laser treatment for scar removal, one of the primary factors that could slow the projected expansion of the world market for scar therapy. The COVID-19 outbreak is likely to have a detrimental impact on the expansion of the scar therapy sector as most hospitals are not accepting outpatients owing to lockdowns.
The COVID-19 virus increases the chance of death in patients with preexisting illnesses like diabetes and cardiovascular disease. Numerous elective surgeries have been rescheduled or delayed as a result of the COVID-19 pandemic's heightened demand for healthcare facilities. The healthcare industry has been reorganized to create more secure medical centres. As a result, post-pandemic conditions are expected to boost market growth.
The scar management market is segmented based on product, scar type and end user. As per the product, the market is segmented into silicon gel and spray, silicon dressing, cream and ointment, and Others. By scar type, the market is segmented into atrophic Scars, Hypertrophic and Keloid Scars, and Others. By end user, the market is segmented into hospitals, speciality clinics, and home healthcare.
The silicone gel scar management market is expected to hold a major global market share in 2022. The silicone gel is for the relief of skin irritation and burns caused by radiation therapy. This treatment is intended to restore and protect the skin from radiation damage while also increasing hydration and suppleness.
The atrophic is projected to grow rapidly in the global Scar management market due to developing at a higher rate than the total market throughout the projected period, primarily as a result of an increase in surgical procedures, especially in countries like the US, Germany, the UK, China, and India.
The North American scar management market is expected to record the maximum market share in revenue in the near future. It can be attributed to the fact that increased government spending because of rising concerns about the look, the widespread availability of scar treatment products, growing disposable incomes, improved hospital infrastructure, and general acceptance of cutting-edge medical technology. In addition, Asia Pacific is estimated to grow rapidly because scar management anticipated that leading players in the area will continue to implement growth strategies, such as product releases, to fuel the market's expansion over the forecast period.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 1.02 Bn |
|
Revenue Forecast In 2031 |
USD 1.64 Bn |
|
Growth Rate CAGR |
CAGR of 5.61% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Scar Type, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Advancis Medical, Bayer AG, B. Braun S.E, Bio Med Sciences, Inc., Covalon Technologies Ltd., Derma E, Molnlycke Health Care AB, Newmedical Technology Inc., Quantum Health, Smith & Nephew, Sonoma Pharmaceuticals, Inc., Stratpharma AG, Scar Heal, Inc., Weigao Group, Winner Medical Co., Ltd. and others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Scar Management Market Snapshot
Chapter 4. Global Scar Management Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Product:
5.2.1. Silicone Gel and Spray
5.2.2. Silicon Dressing
5.2.3. Cream and Ointment
5.2.4. Others
Chapter 6. Market Segmentation 2: By Scar Type Estimates & Trend Analysis
6.1. By Scar Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Scar Type:
6.2.1.
6.2.2. Atrophic Scars
6.2.3. Hypertrophic and Keloid Scars
6.2.4. Others
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
7.2.1. Hospitals
7.2.2. Specialty Clinics
7.2.3. Home Healthcare (Over the Counter (OTC))
Chapter 8. Scar Management Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Scar Management Market revenue (US$ Million) estimates and forecasts By Product, 2019-2031
8.1.2. North America Scar Management Market revenue (US$ Million) estimates and forecasts By Scar Type, 2019-2031
8.1.3. North America Scar Management Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
8.1.4. North America Scar Management Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Scar Management Market revenue (US$ Million) By Product, 2019-2031
8.2.2. Europe Scar Management Market revenue (US$ Million) By Scar Type, 2019-2031
8.2.3. Europe Scar Management Market revenue (US$ Million) By End User, 2019-2031
8.2.4. Europe Scar Management Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Scar Management Market revenue (US$ Million) By Product, 2019-2031
8.3.2. Asia Pacific Scar Management Market revenue (US$ Million) By Scar Type, 2019-2031
8.3.3. Asia Pacific Scar Management Market revenue (US$ Million) By End User, 2019-2031
8.3.4. Asia Pacific Scar Management Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Scar Management Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.4.2. Latin America Scar Management Market revenue (US$ Million) By Scar Type, (US$ Million) 2019-2031
8.4.3. Latin America Scar Management Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.4.4. Latin America Scar Management Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Scar Management Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Scar Management Market revenue (US$ Million) By Scar Type, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Scar Management Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Scar Management Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Advancis Medical
9.2.2. Bayer AG
9.2.3. B. Braun S.E.
9.2.4. Bio Med Sciences, Inc.
9.2.5. Covalon Technologies Ltd.
9.2.6. Derma E
9.2.7. Mölnlycke Health Care AB
9.2.8. Newmedical Technology Inc.
9.2.9. Quantum Health
9.2.10. Smith & Nephew
9.2.11. Sonoma Pharmaceuticals, Inc.
9.2.12. Stratpharma AG
9.2.13. Scar Heal, Inc.
9.2.14. Weigao Group
9.2.15. Winner Medical Co., Ltd.
Scar Management Market By Product-
Scar Management Market By Scar Type-
Scar Management Market By End User-
Scar Management Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
